Skip to main content

Table 1 Characteristics of preclinical studies investigating the therapeutic efficacy of MSCs in AAA models

From: Therapeutic efficacy of mesenchymal stem cells for abdominal aortic aneurysm: a meta-analysis of preclinical studies

Author

Year

Country

No. of MSC group

No. of control group

AAA model

Animal species

MSC source

Cell compatibility

Intervention route

Total dose (cells)

Control

Follow-up duration (days)

Hashizume [28]

2011

Japan

7

6

AngII

apoE−/− mice

Bone marrow

Allogenic

Perivascular

1*105

NS

28

Sharma [15]

2012

USA

6

8

Elastase

C57BL/6 mice

Placenta

Xenogenic

Intravenous

1*106

NS

14

Fu-1 [27]

2013

Japan

10

5

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

28

Fu-2 [27]

2013

Japan

12

5

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

4*106

Saline

28

Schneider-1 [32]

2013

France

6

3

Xenograft

Fischer rats

Bone marrow

Allogenic

Intraluminal

1*106

medium

7

Schneider-2 [32]

2013

France

5

3

Xenograft

Fischer rats

Bone marrow

Allogenic

Intraluminal

1*106

medium

28

Blose [21]

2014

USA

7

6

Elastase

C57BL/6 mice

Adipose tissue

Allogenic

Perivascular

1*105

Saline

9

Yamawaki-Ogata-1 [30]

2014

Japan

10

10

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

14

Yamawaki-Ogata-2 [30]

2014

Japan

7

6

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

28

Yamawaki-Ogata-3 [30]

2014

Japan

6

5

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

56

Zidi [33]

2015

France

6

6

Xenograft

Fischer rats

Bone marrow

Allogenic

Intraluminal

1*106

NS

7

Davis-1 [22]

2015

USA

11

4

Elastase

C57BL/6 mice

Bone marrow

Allogenic

Intravenous

9 × 106

NS

14

Davis-2 [22]

2015

USA

9

4

Elastase

C57BL/6 mice

Bone marrow

Allogenic

Intravenous

9 × 106

NS

14

Sharma [23]

2016

USA

8

8

Elastase

C57BL/6 mice

Umbilical cord

Xenogenic

Intravenous

1*106

NS

14

Xie-1 [25]

2017

USA

4

4

Elastase

C57BL/6 mice

Adipose tissue

Xenogenic

Intravenous

1*106

PBS

4

Xie-2 [25]

2017

USA

5

5

Elastase

C57BL/6 mice

Adipose tissue

Xenogenic

Intravenous

1*106

PBS

7

Xie-3 [25]

2017

USA

4

4

Elastase

C57BL/6 mice

Adipose tissue

Xenogenic

Intravenous

1*106

PBS

14

Yamawaki-Ogata [31]

2017

Japan

5

5

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

14

Hosoyama-1 [29]

2018

Japan

24

8

Elastase CaCl2

SCID mice

Bone marrow

Xenogenic

Intravenous

6*104

PBS

7, 14, 21

Hosoyama-2 [29]

2018

Japan

24

8

Elastase CaCl2

SCID mice

Bone marrow

Xenogenic

Intravenous

6*104

PBS

28, 35, 42, 56, 64

Parvizi [36]

2018

Netherlands

6

6

Elastase CaCl2

Fischer rats

Adipose tissue

Allogenic

Perivascular

2*106

NS

14

Spinosa [24]

2018

USA

12

12

Elastase

C57BL/6 mice

Umbilical cord

Xenogenic

Intravenous

1*106

NS

14

Zidi [34]

2018

France

6

6

Xenograft

Fischer rats

Bone marrow

Allogenic

Intraluminal

1*106

NS

7

Zhou [35]

2019

China

8

8

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

2*106

medium

14

Wen-1 [16]

2020

China

10

5

Elastase

SD rats

Umbilical cord

Xenogenic

Intravenous

1*106

Saline

7

Wen-2 [16]

2020

China

10

5

Elastase

SD rats

Umbilical cord

Xenogenic

Intravenous

1*106

Saline

14

Akita-1 [26]

2021

Japan

10

5

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

14

Akita-2 [26]

2021

Japan

10

5

AngII

apoE−/− mice

Bone marrow

Allogenic

Intravenous

1*106

Saline

14

  1. MSCs, mesenchymal stem cells; AAA, abdominal aortic aneurysm; AngII, angiotensin II; apoE−/−, apolipoprotein E knockout mice; PBS, phosphate buffered saline; NS, not mentioned